ORMP Oramed Pharmaceuticals Inc. - Common Stock

NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗
$4,83
Harga · Agu 19, 2026
Fundamental per Agu 10, 2026

Tentang Oramed Pharmaceuticals Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Baca selengkapnya

Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

History

Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.

Product pipeline

Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.

In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.

In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.

In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.

In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.

On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.

Subsidiaries

OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

ORMP Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

Harga
$4.83
Kapitalisasi Pasar
$197.7K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Pendapatan (TTM)
$2M
Imbal Hasil Dividen
ROE
37.0%
D/E Utang/Ekuitas
Rentang 52M
$2 – $5

ORMP Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

Pendapatan & Laba Bersih $2M
8-point trend, -18.6%
2017-08-31 2025-12-31
EPS $1.50
4-point trend, +259.6%
2022-12-31 2025-12-31
Arus Kas Bebas $-9M
6-point trend, +29.3%
2019-08-31 2025-12-31
Margin 3202.5%
2025-12-31 2025-12-31

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik
Tren 5 Tahun
ORMP
Median Rekan
P/E (TTM)
4-point trend, +114.8%
0.0
23.4
P/S (TTM)
5-point trend, +83.6%
0.1
11.2
P/B
5-point trend, -77.7%
0.0
2.5
Price / FCF (Harga / FCF)
5-point trend, -85.3%
-0.0

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik
Tren 5 Tahun
ORMP
Median Rekan
Gross Margin (Margin Kotor)
0.65%
82.8%
Operating Margin (Margin Operasi)
5-point trend, -73.9%
-754.4%
Net Profit Margin (Margin Laba Bersih)
5-point trend, +854.0%
3202.5%
-199.7%
ROA
5-point trend, +214.3%
33.2%
-34.8%
ROE
5-point trend, +178.7%
37.0%
-33.2%
ROIC
2-point trend, +90.5%
-6.4%

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik
Tren 5 Tahun
ORMP
Median Rekan
Current Ratio (Rasio Lancar)
5-point trend, -21.8%
7.0
1.5
Quick Ratio (Rasio Cepat)
5-point trend, -46.0%
2.7

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik
Tren 5 Tahun
ORMP
Median Rekan
Revenue YoY (Pendapatan YoY)
5-point trend, -26.2%
-50.4%
Revenue CAGR 3Y (CAGR Pendapatan 3T)
5-point trend, -26.2%
-9.6%

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik
Tren 5 Tahun
ORMP
Median Rekan
EPS (Diluted)
4-point trend, +259.6%
$1.50

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik
Tren 5 Tahun
ORMP
Median Rekan

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

Imbal Hasil Dividen
Rasio Pembayaran Dividen
CAGR Dividen 5T
Tanggal ex-dividenJumlah
16 Jan. 2026$0,2500

ORMP Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

JUAL 6 analis
  • Beli Kuat 0 0,0%
  • Beli 0 0,0%
  • Tahan 3 50,0%
  • Jual 1 16,7%
  • Jual Kuat 2 33,3%

Target Harga 12 Bulan

1 analis · 2026-08-17
Target median $6.25 +29,4%
Target rata-rata $6.25 +29,4%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

Kejutan Rata-rata
0.32%
Periode EPS Aktual EPS Estimasi Kejutan
31 Des. 2025 $0.24 $0.00 0.24%
30 Sep. 2025 $1.12 $-0.04 1.2%
30 Juni 2025 $0.31 $-0.04 0.35%
31 Maret 2025 $-0.19 $-0.01 -0.18%
31 Des. 2024 $0.00 $-0.03 0.03%

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
ORMP $112M 1.9 -50.4% 3202.5% 37.0% 0.65%
TTRX $116M -32.8 -141.7%
ANTX $31M -1.0 -57.7%
SIGA $438M 19.1 -31.8% 24.6% 11.4%
DERM -16.4 10.2% -18.5% -44.7%
LENZ $502M -5.6 -430.2% -33.5%
NRXP
LLY 46.8 44.7% 31.7% 101.2%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

Laporan Laba Rugi 17
Data Laporan Laba Rugi Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Revenue 7-point trend, -18.6% $2M · $1M $3M · $3M $3M $2M $2M
Cost of Revenue 4-point trend, +962.6% $2M · · · · · $90.0K $-86.0K $187.0K
Gross Profit $13.0K · · · · · · · ·
R&D Expense 8-point trend, -37.9% $6M $6M $9M $28M · $10M $14M $12M $10M
SG&A Expense 8-point trend, +216.1% $9M $6M $8M $14M · $4M $4M $4M $3M
Operating Income 8-point trend, -40.1% $-15M $-13M $-16M $-41M · $-12M $-15M $-14M $-11M
Interest Expense · · $2M · · · · · ·
Interest Income · · $10.0K · · · · · ·
Other Non-op 4-point trend, -120.7% $-606.0K $-27.0K $13.3K $3M · · · · ·
Pretax Income 8-point trend, +847.3% $75M $-16M $5M $-38M · $-12M $-14M $-13M $-10M
Income Tax 5-point trend, +2727.0% $11M $3M · $100.0K · · $300.0K · $400.0K
Net Income 8-point trend, +711.2% $64M $-19M $5M $-37M · $-12M $-14M $-13M $-10M
EPS (Basic) 4-point trend, +262.8% $1.53 $-0.48 $0.14 $-0.94 · · · · ·
EPS (Diluted) 4-point trend, +259.6% $1.50 $-0.48 $0.14 $-0.94 · · · · ·
Shares (Basic) 4-point trend, +6.2% 41,402,997 40,850,446 40,315,068 38,997,649 · · · · ·
Shares (Diluted) 4-point trend, +8.8% 42,418,644 40,850,446 40,566,901 38,997,649 · · · · ·
EBITDA 5-point trend, -3.1% $-15M · $-16M $-41M · $-12M $-15M · ·
Neraca 23
Data Neraca Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Cash & Equivalents 8-point trend, +1057.6% $46M $54M $9M $40M · $19M $3M $5M $4M
Short-term Investments 5-point trend, +18.0% $5M $3M · · $8M $3M · $5M ·
Prepaid Expense 7-point trend, +377.5% $3M $1M $537.0K $1M · $611.0K $1M $574.0K ·
Current Assets 8-point trend, +329.4% $133M $143M $163M $157M $148M $41M $33M $31M ·
PP&E (Net) 8-point trend, +3347.1% $586.0K $698.0K $873.0K $815.0K $388.0K $99.0K $24.0K $17.0K ·
Other Non-current Assets 3-point trend, +63.0% $44.0K $32.0K $27.0K · · · · · ·
Total Assets 8-point trend, +387.1% $231M $155M $221M $162M $178M $45M $35M $47M ·
Accounts Payable 8-point trend, -78.5% $443.0K $789.0K $551.0K $4M $5M $2M $3M $2M ·
Accrued Liabilities 3-point trend, +79.2% $1M $402.0K $605.0K · · · · · ·
Short-term Debt 5-point trend, -73.4% $652.0K $329.0K $51M · · · $3M $2M ·
Current Liabilities 8-point trend, +319.2% $19M $6M $53M $6M $7M $5M $5M $5M ·
Capital Leases 6-point trend, +1641.9% $540.0K $156.0K $342.0K $647.0K $370.0K $31.0K · · ·
Deferred Tax $8M · · · · · · · ·
Other Non-current Liabilities 5-point trend, -80.8% · $60.0K $63.0K · · $211.0K $271.0K $313.0K ·
Long-term Debt 4-point trend, -99.8% · · · $25.0K $12M · $10M $11M ·
Total Debt 2-point trend, +1787.3% · · $51M · · · $3M · ·
Common Stock 8-point trend, +128.0% $472.0K $480.0K $485.0K $476.0K $459.0K $284.0K $208.0K $207.0K ·
Paid-in Capital 3-point trend, +151.1% · · · $314M $293M $125M · · ·
Retained Earnings 8-point trend, -78.3% $-123M $-177M $-158M $-163M $-127M $-93M $-81M $-69M ·
AOCI · · · · · · · $702.0K ·
Stockholders' Equity 9-point trend, +938.3% $200M $145M $164M $152M $166M $33M $19M $31M $19M
Liabilities + Equity 8-point trend, +387.1% $231M $155M $221M $162M $178M $45M $35M $47M ·
Shares Outstanding 8-point trend, +126.1% 39,275,006 39,920 40,339,000 39,564,000 38,158 23,675,530 17,383,359 17,369,875 ·
Arus Kas 12
Data Arus Kas Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Stock-based Comp 8-point trend, +280.4% $6M $4M $4M $12M · $465.0K $808.0K $2M $2M
Deferred Tax $8M · · · · · · · ·
Operating Cash Flow 8-point trend, -56.8% $-9M $-8M $-10M $-28M · $-12M $-13M $-15M $-6M
CapEx 8-point trend, +28.6% $9.0K $18.0K $254.0K $496.0K · $82.0K $15.0K $5.0K $7.0K
Investing Cash Flow 8-point trend, +26.5% $5M $106M $-73M $30M · $5M $11M $-7M $4M
Stock Issued 2-point trend, -78.9% · · $2M $12M · · · · ·
Stock Repurchased 2-point trend, +90.9% $5M $2M · · · · · · ·
Net Stock Activity 3-point trend, -144.7% $-5M · $2M $11M · · · · ·
Financing Cash Flow 7-point trend, -398.9% $-5M $-52M $52M $11M · $24M · $23M $2M
Net Change in Cash 8-point trend, -13766.1% $-8M $45M $-31M $13M · $16M $-2M $1M $62.0K
Taxes Paid 4-point trend, +479.0% · $2M · $2M · · $300.0K · $400.0K
Free Cash Flow 5-point trend, +29.3% $-9M · $-11M $-28M · $-13M $-13M · ·
Profitabilitas 8
Data Profitabilitas Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Gross Margin 0.65% · · · · · · · ·
Operating Margin 5-point trend, -39.4% -754.4% · -1176.8% -1502.0% · -433.8% -541.3% · ·
Net Margin 5-point trend, +703.0% 3202.5% · 412.3% -1397.1% · -424.8% -531.1% · ·
Pretax Margin 4-point trend, +824.3% 3766.2% · 379.7% · · -424.8% -520.0% · ·
EBITDA Margin 5-point trend, -39.4% -754.4% · -1176.8% -1502.0% · -433.8% -541.3% · ·
ROA 5-point trend, +194.8% 33.2% · 2.9% -22.2% · -29.0% -35.0% · ·
ROE 5-point trend, +152.8% 37.0% · 3.5% -23.7% · -47.0% -70.1% · ·
ROIC 2-point trend, +90.5% -6.4% · · · · · -67.6% · ·
Likuiditas & Solvabilitas 4
Data Likuiditas & Solvabilitas Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Current Ratio 5-point trend, +11.2% 7.0 · 3.1 27.3 · 8.9 6.3 · ·
Quick Ratio 5-point trend, +103.2% 2.7 · 1.3 0.7 · 5.0 1.3 · ·
Debt / Equity 2-point trend, +123.4% · · 0.3 · · · 0.1 · ·
Interest Coverage · · -7.7 · · · · · ·
Efisiensi 1
Data Efisiensi Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Asset Turnover 5-point trend, -84.2% 0.0 · 0.0 0.0 · 0.1 0.1 · ·
Per Saham 6
Data Per Saham Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Book Value / Share 5-point trend, +355.9% $5.09 · $4.06 $3.84 · $1.39 $1.12 · ·
Revenue / Share 3-point trend, -32.0% $0.05 · $0.03 $0.07 · · · · ·
Cash Flow / Share 3-point trend, +69.9% $-0.22 · $-0.25 $-0.72 · · · · ·
Cash / Share 4-point trend, +510.9% $1.17 · $0.22 · · $0.81 $0.19 · ·
Dividend Paid / Share $0 · · · · · · · ·
EPS (TTM) 4-point trend, +259.6% $1.50 $-0.48 $0.14 $-0.94 · · · · ·
Tingkat Pertumbuhan 2
Data Tingkat Pertumbuhan Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Revenue YoY · · -50.4% · · · · · ·
Revenue CAGR 3Y -9.6% · · · · · · · ·
Valuasi (TTM) 14
Data Valuasi (TTM) Tahunan untuk ORMP
Metrik Tren 202520242023202220212020201920182017
Revenue TTM 8-point trend, -18.6% $2M $3M $1M $3M · $3M $3M $2M $2M
Net Income TTM 8-point trend, +711.2% $64M $-19M $5M $-37M · $-12M $-14M $-13M $-10M
Market Cap 5-point trend, +93.9% $112M · $93M $476M · $83M $58M · ·
Enterprise Value 2-point trend, +45.0% · · $77M · · · $53M · ·
P/E 4-point trend, +114.8% 1.9 -5.0 16.5 -12.8 · · · · ·
P/S 5-point trend, +162.1% 56.0 · 69.5 176.1 · 30.5 21.4 · ·
P/B 5-point trend, -81.2% 0.6 · 0.6 3.1 · 2.5 3.0 · ·
P / Tangible Book 5-point trend, -77.7% 0.6 0.7 0.6 3.1 · 2.5 · · ·
P / Cash Flow 5-point trend, -174.4% -12.2 · -9.1 -17.0 · -6.6 -4.5 · ·
P / FCF 5-point trend, -174.5% -12.2 · -8.8 -16.8 · -6.6 -4.5 · ·
EV / EBITDA 2-point trend, -34.6% · · -4.9 · · · -3.6 · ·
EV / FCF 2-point trend, -78.1% · · -7.3 · · · -4.1 · ·
EV / Revenue 2-point trend, +192.6% · · 57.8 · · · 19.8 · ·
Earnings Yield 4-point trend, +773.9% 52.6% -19.8% 6.1% -7.8% · · · · ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

Laporan Laba Rugi
2025-12-312024-12-312023-12-312022-12-312021-12-31
Pendapatan $2M$1M$3M
Margin Kotor % 0.65%
Margin Operasi % -754.4%-1176.8%-1502.0%
Laba Bersih $64M$-19M$5M$-37M
EPS Dilusian $1.50$-0.48$0.14$-0.94
Neraca
2025-12-312024-12-312023-12-312022-12-312021-12-31
Utang / Ekuitas 0.3
Rasio Lancar 7.03.127.3
Rasio Cepat 2.71.30.7
Arus Kas
2025-12-312024-12-312023-12-312022-12-312021-12-31
Arus Kas Bebas $-9M$-11M$-28M

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

📊

Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Pemilik institusional (13F) 88 pengaju · $64.4M total · Per tanggal 30 Juni 2026

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
30 (+13 vs Kuartal sebelumnya) 8 (0 vs Kuartal sebelumnya) 19 (-1 vs Kuartal sebelumnya) 19 (+5 vs Kuartal sebelumnya) -209K

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
Aquamarine Financial (Cayman) Ltd $12.083.562 2.512.175 18,77% Saham
Gem Investment Advisors, LLC $9.614.238 1.998.802 14,94% Saham
MERCER GLOBAL ADVISORS INC /ADV $9.189.697 1.910.540 14,28% Saham
Murchinson Ltd. $6.206.314 1.290.294 9,64% Saham
SB Capital Management Inc $5.415.000 1.900.000 8,41% Saham
BML Capital Management, LLC $4.166.754 866.269 6,47% Saham
BOOTHBAY FUND MANAGEMENT, LLC $2.783.249 578.638 4,32% Saham
GEODE CAPITAL MANAGEMENT, LLC $2.162.008 449.482 3,36% Saham
STATE STREET CORP $1.164.501 242.100 1,81% Saham
Rathbones Group PLC $1.120.816 233.018 1,74% Saham
VANGUARD PORTFOLIO MANAGEMENT LLC $1.105.732 229.882 1,72% Saham
GOLDMAN SACHS GROUP INC $950.908 197.694 1,48% Saham
RENAISSANCE TECHNOLOGIES LLC $884.078 183.800 1,37% Saham
DIMENSIONAL FUND ADVISORS LP $784.896 163.180 1,22% Saham
STRS OHIO $643.578 133.800 1,00% Saham
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $495.247 102.962 0,77% Saham
JANE STREET GROUP, LLC $470.606 97.839 0,73% Saham
Hillsdale Investment Management Inc. $429.533 89.300 0,67% Saham
RITHOLTZ WEALTH MANAGEMENT $405.709 84.347 0,63% Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $402.280 83.634 0,63% Saham
AMERICAN CENTURY COMPANIES INC $287.518 59.775 0,45% Saham
XTX Topco Ltd $240.130 49.923 0,37% Saham
Nuveen, LLC $223.203 46.404 0,35% Saham
DEUTSCHE BANK AG\ $159.682 33.198 0,25% Saham
PRELUDE CAPITAL MANAGEMENT, LLC $157.350 32.713 0,24% Saham
BAILARD, INC. $156.219 32.478 0,24% Saham
RHUMBLINE ADVISERS $147.281 30.621 0,23% Saham
Bank of New York Mellon Corp $143.016 29.733 0,22% Saham
ALGERT GLOBAL LLC $139.288 28.958 0,22% Saham
WELLS FARGO & COMPANY/MN $137.080 28.499 0,21% Saham
Connor, Clark & Lunn Investment Management Ltd. $121.246 25.207 0,19% Saham
CITADEL ADVISORS LLC $120.250 25.000 0,19% Opsi beli
SUSQUEHANNA INTERNATIONAL GROUP, LLP $107.263 22.300 0,17% Saham
MILLENNIUM MANAGEMENT LLC $105.151 21.861 0,16% Saham
PNC Financial Services Group, Inc. $101.972 21.200 0,16% Saham
Redwood Family Wealth LLC $99.783 20.745 0,16% Saham
BANK OF AMERICA CORP /DE/ $91.621 19.048 0,14% Saham
MORGAN STANLEY $87.994 18.294 0,14% Saham
Sage Capital Management, LLC $86.474 17.977 0,13% Saham
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $75.378 15.671 0,12% Saham
VANGUARD FIDUCIARY TRUST CO $67.811 14.098 0,11% Saham
CITIGROUP INC $66.590 13.844 0,10% Saham
JPMORGAN CHASE & CO $65.461 14.108 0,10% Saham
Invesco Ltd. $65.272 13.570 0,10% Saham
Y-Intercept (Hong Kong) Ltd $61.650 12.817 0,10% Saham
Engineers Gate Manager LP $61.077 12.698 0,09% Saham
Altshuler Shaham Ltd $53.925 11.211 0,08% Saham
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC $52.096 12.895 0,08% Saham
Glass Jacobson Investment Advisors llc $50.698 10.540 0,08% Saham
Police & Firemen's Retirement System of New Jersey $50.115 10.419 0,08% Saham
MARSHALL WACE, LLP $50.024 10.400 0,08% Saham
Hudson Bay Capital Management LP $49.375 10.265 0,08% Saham
BNP PARIBAS FINANCIAL MARKETS $47.706 9.918 0,07% Saham
Steward Partners Investment Advisory, LLC $42.453 8.826 0,07% Saham
BARCLAYS PLC $27.917 5.804 0,04% Saham
NEW YORK STATE COMMON RETIREMENT FUND $25.974 5.400 0,04% Saham
NORTHERN TRUST CORP $25.503 5.302 0,04% Saham
Tower Research Capital LLC (TRC) $23.218 4.827 0,04% Saham
OSAIC HOLDINGS, INC. $20.283 4.217 0,03% Saham
FEDERATED HERMES, INC. $19.221 3.996 0,03% Saham
N.E.W. Advisory Services LLC $16.495 3.429 0,03% Saham
Legal & General Group Plc $15.979 3.322 0,02% Saham
CITADEL ADVISORS LLC $15.565 3.236 0,02% Saham
Ameritas Investment Partners, Inc. $14.853 3.088 0,02% Saham
HUNTINGTON NATIONAL BANK $14.440 3.002 0,02% Saham
Pioneer Family Office, LLC $14.430 3.000 0,02% Saham
Russell Investments Group, Ltd. $13.088 2.721 0,02% Saham
UBS Group AG $12.987 2.700 0,02% Saham
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $7.576 1.575 0,01% Saham
MetLife Investment Management, LLC $7.037 1.463 0,01% Saham
BlackRock, Inc. $6.768 1.407 0,01% Saham
ROYAL BANK OF CANADA $6.000 1.246 0,01% Saham
MCF Advisors LLC $5.162 1.073 0,01% Saham
Caitlin John, LLC $4.810 1.000 0,01% Saham
McIlrath & Eck, LLC $3.400 1.000 0,01% Saham
Sterling Capital Management LLC $3.300 686 0,01% Saham
IFP Advisors, Inc $2.405 500 0,00% Saham
PROEQUITIES, INC. $2.310 1.000 0,00% Saham
Golden State Wealth Management, LLC $1.458 303 0,00% Saham
JONES FINANCIAL COMPANIES LLLP $999 214 0,00% Saham
HRT FINANCIAL LP $469 97.582 0,00% Saham
FMR LLC $332 69 0,00% Saham
SBI Securities Co., Ltd. $284 59 0,00% Saham
PRICE T ROWE ASSOCIATES INC /MD/ $135 27.909 0,00% Saham
TrinityBridge Ltd $56 11.675 0,00% Saham
HARBOUR INVESTMENTS, INC. $48 10 0,00% Saham
Caitong International Asset Management Co., Ltd $29 6 0,00% Saham
ACADIAN ASSET MANAGEMENT LLC $8 1.691 0,00% Saham

Orang dalam perusahaan 30 orang dalam · 13 pejabat · 16 direktur

Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Nadav Kidron President and CEO 30 Maret 2026 F 3.422.243 0 0 $0
Avraham Gabay Chief Financial Officer 1 Juli 2026 S 671.785 0 1 $-330.854
David Silberman Chief Financial Officer 4 Jan. 2024 A 366.500 0 0 $0
Hilla Eisenberg CFO, Treasurer and Secretary 26 Feb. 2019 A 0 0 $0
Yifat Hen Zommer CFO, Treasurer and Secretary 30 Juni 2017 A 46.560 0 0 $0
Chaime Orlev CFO, Treasurer and Secretary 12 Okt. 2008 A 0 0 $0
Joshua Hexter COO & CBO 2 Juli 2026 M 1.073.384 0 1 $-611.020
Miriam Kidron Chief Scientific Officer 30 Maret 2026 F 1.133.138 0 0 $0
Netanel Derovan Chief Legal Officer 26 Mei 2023 A 149.500 0 0 $0
Michael Rabinowitz Chief Commercial Officer 3 Jan. 2023 S 126.143 0 0 $0
Michael Rabinowitz Chief Commercial Officer 3 Jan. 2022 A 109.468 0 0 $0
Mark Daniel Hasleton VP Business Development 26 Feb. 2019 A 0 0 $0
Ronald Edward Law Chief Strategy Officer 20 Maret 2017 A 0 0 $0
Yehuda Reznick Direktur 31 Des. 2025 A 105.180 0 0 $0
Daniel Aghion Direktur 31 Des. 2025 A 113.441 0 0 $0
Benjamin Shapiro Direktur 31 Des. 2025 A 123.220 0 0 $0
Arie Mayer Direktur 31 Des. 2025 A 168.009 0 0 $0
Leonard Sank Direktur 5 Juni 2025 A 134.531 0 0 $0
Yadin Rozov Direktur 4 Jan. 2024 A 155.320 0 0 $0
Kevin Rakin Direktur 21 Maret 2022 S 46.661 0 0 $0
Aviad Friedman Direktur 3 Jan. 2022 G 0 0 0 $0
Gao Xiaoming Direktur 8 Jan. 2020 A 0 0 $0
David Mark Slager Direktur 15 April 2019 A 1.316.328 0 0 $0
Xiaopeng Li Direktur 2 Agu 2017 P 206.350 0 0 $0
Harold Jacob Direktur 10 Maret 2016 S 16.396 0 0 $0
Michael Berelowitz Direktur 9 Des. 2015 S 22.896 0 0 $0
Gerald M Ostrov Direktur 23 Feb. 2015 A 24.896 0 0 $0
REGALS CAPITAL MANAGEMENT LP Pemilik 10% 23 Des. 2015 X 1.186.823 0 0 $0
Zeev Bronfeld Pemilik 10% 27 Sep. 2011 S 5.808.517 0 0 $0
Michael Young 27 Mei 2004 S 0 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Aktivis & pemilik 5%+ 9 saham

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
Oramed Pharmaceuticals Inc. 22 Juli 2026 3,30% Amandemen SEC
Nadav Kidron ×8 pengajuan 28 Agu 2025 7,60% Amandemen SEC
Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 pengajuan 20 Juli 2018 Pengajuan awal SEC
Hefei Tianhui Incubator of Technologies Co., Ltd 6 Jan. 2016 Pengajuan awal SEC
Leonard Sank 15 Des. 2014 Pengajuan awal Investasi pasif SEC
Miriam Kidron ×2 pengajuan 3 Feb. 2014 Pengajuan awal SEC
Zeev Bronfeld 6 Maret 2006 Pengajuan awal Investasi pasif SEC
Orang pelapor yang tidak diungkapkan 10 Juni 2004 Pengajuan awal SEC
Orang pelapor yang tidak diungkapkan 10 Juni 2004 Pengajuan awal Investasi pasif SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Kepemilikan ETF Dimiliki oleh 14 ETF

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
AVSC · AMERICAN CENTURY ETF TRUST 0,00% 28.155 NS 31 Mei 2026 N-PORT
DFAS · Dimensional ETF Trust 0,00% 26.896 NS 30 April 2026 N-PORT
DCOR · Dimensional ETF Trust 0,00% 4.523 NS 30 April 2026 N-PORT
DFAC · Dimensional ETF Trust 0,00% 36.536 NS 30 April 2026 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0,00% 4.152 NS 31 Mei 2026 N-PORT
DFUS · Dimensional ETF Trust 0,00% 3.431 NS 30 April 2026 N-PORT
DXUV · Dimensional ETF Trust 0,00% 4 NS 30 April 2026 N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS 15 Juli 2026 Harian
VTWV · VANGUARD SCOTTSDALE FUNDS 15 Juli 2026 Harian
VTHR · VANGUARD SCOTTSDALE FUNDS 15 Juli 2026 Harian
IWN · iShares Trust 17 Agu 2026 Harian
IWM · iShares Trust 18 Agu 2026 Harian
IWC · iShares Trust 18 Agu 2026 Harian
OMFS · Invesco Exchange-Traded Self-Indexe… 13 Juli 2026 Harian